Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and man
- PMID: 102086
- DOI: 10.3109/00498257809069574
Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and man
Abstract
1. Following an oral dose of S-carboxymethyl [35S]cysteine monkey (rhesus and African green), rat, dog, and man excreted 77,88,95, and 100% respectively of the 35S radioactivity in urine and 7.0, 2.5, 0.7, and 0.3% in faeces during a 3 to 4 day period. 2. The principal drug-related components excreted were unchanged carboxymethylcysteine, dicarboxymethyl sulphide and inorganic sulphate. 3. Rat, dog, and man excreted primarily dicarboxymethyl sulphide and unchanged carboxymethylcysteine and no inorganic sulphate (rat, 7%). 4. Monkey excreted largely inorganic sulphate, moderate amounts of dicarboxymethyl sulphide and a trace of unchanged drug.
Similar articles
-
The metabolism and elimination of S-carboxymethyl-L-cysteine in man.Drug Metab Dispos. 1982 Jan-Feb;10(1):61-2. Drug Metab Dispos. 1982. PMID: 6124385
-
Sulphoxidation of S-carboxymethyl-L-cysteine in the rhesus monkey (Macaca mulatta), cynomologus monkey (Macaca fascicularis), African green monkey (Cercopithecus aethiops) and the marmoset (Callithrix jacchus).Comp Biochem Physiol B. 1986;84(2):143-4. doi: 10.1016/0305-0491(86)90195-1. Comp Biochem Physiol B. 1986. PMID: 3089678
-
The metabolism of S-carboxymethylcysteine in rodents, marmosets and humans.Xenobiotica. 1978 May;8(5):265-70. doi: 10.3109/00498257809060949. Xenobiotica. 1978. PMID: 96615
-
The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.Pharmacol Ther. 1989;43(2):237-49. doi: 10.1016/0163-7258(89)90120-4. Pharmacol Ther. 1989. PMID: 2675135 Review. No abstract available.
-
Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.Drug Metabol Drug Interact. 1988;6(3-4):253-63. doi: 10.1515/dmdi.1988.6.3-4.253. Drug Metabol Drug Interact. 1988. PMID: 3078290 Review.
Cited by
-
Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.Eur J Clin Pharmacol. 1991;40(4):387-92. doi: 10.1007/BF00265849. Eur J Clin Pharmacol. 1991. PMID: 2050173
-
An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.Eur J Drug Metab Pharmacokinet. 1988 Oct-Dec;13(4):253-6. doi: 10.1007/BF03190087. Eur J Drug Metab Pharmacokinet. 1988. PMID: 3243319
-
High pressure liquid chromatographic determination of carbocisteine in human plasma and urine.Pharm Weekbl Sci. 1986 Apr 25;8(2):134-8. doi: 10.1007/BF02086147. Pharm Weekbl Sci. 1986. PMID: 3086832
-
Variation in human metabolism of S-carboxymethylcysteine.Eur J Drug Metab Pharmacokinet. 1980;5(1):49-52. doi: 10.1007/BF03189444. Eur J Drug Metab Pharmacokinet. 1980. PMID: 7389752
-
Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.Br J Clin Pharmacol. 1984 Oct;18(4):507-21. doi: 10.1111/j.1365-2125.1984.tb02498.x. Br J Clin Pharmacol. 1984. PMID: 6487492 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources